| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,214 |
19,708 |
$4.34M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,737 |
16,566 |
$4.11M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,098 |
9,135 |
$3.28M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,123 |
3,980 |
$711K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,212 |
1,169 |
$626K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,832 |
5,406 |
$530K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,813 |
4,166 |
$385K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,440 |
2,339 |
$359K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,998 |
3,490 |
$347K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,323 |
1,268 |
$328K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,623 |
1,264 |
$239K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,487 |
1,308 |
$237K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
652 |
630 |
$233K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,082 |
1,044 |
$228K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,111 |
2,712 |
$219K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,877 |
3,558 |
$214K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,991 |
15,194 |
$182K |
| 87631 |
|
973 |
952 |
$169K |
| 71046 |
Radiologic examination, chest; 2 views |
2,043 |
1,954 |
$165K |
| G0378 |
Hospital observation service, per hour |
235 |
214 |
$155K |
| 71045 |
Radiologic examination, chest; single view |
2,274 |
2,111 |
$153K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
981 |
867 |
$149K |
| 80053 |
Comprehensive metabolic panel |
10,065 |
9,458 |
$138K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
558 |
486 |
$133K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,219 |
3,184 |
$123K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,462 |
5,317 |
$119K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,013 |
2,480 |
$118K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,286 |
2,250 |
$112K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,283 |
2,249 |
$111K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,831 |
1,637 |
$101K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,015 |
6,884 |
$92K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
487 |
477 |
$74K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
612 |
602 |
$71K |
| 73562 |
|
549 |
509 |
$69K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,599 |
657 |
$69K |
| 84484 |
|
3,012 |
2,446 |
$69K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,204 |
1,179 |
$61K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,132 |
5,047 |
$56K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,183 |
1,158 |
$56K |
| 83690 |
|
3,679 |
3,332 |
$52K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
618 |
215 |
$52K |
| 73610 |
|
351 |
328 |
$49K |
| 80306 |
|
1,552 |
1,445 |
$47K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,763 |
4,445 |
$47K |
| 36415 |
Collection of venous blood by venipuncture |
6,809 |
6,259 |
$43K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
807 |
783 |
$43K |
| 73030 |
|
284 |
257 |
$40K |
| 84439 |
|
3,330 |
3,267 |
$40K |
| 87650 |
|
1,235 |
1,211 |
$39K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
185 |
183 |
$38K |
| 81025 |
|
3,086 |
2,943 |
$38K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
337 |
314 |
$37K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,084 |
2,001 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,831 |
1,787 |
$37K |
| 73630 |
|
416 |
381 |
$37K |
| 81001 |
|
5,556 |
5,151 |
$35K |
| 80076 |
|
3,103 |
2,889 |
$33K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
52 |
52 |
$30K |
| 81513 |
|
190 |
183 |
$28K |
| 83605 |
|
1,845 |
1,500 |
$27K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
761 |
754 |
$27K |
| 96376 |
|
633 |
470 |
$26K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,705 |
1,467 |
$26K |
| 87040 |
|
1,019 |
685 |
$25K |
| 87077 |
|
1,853 |
1,736 |
$25K |
| 82728 |
|
1,293 |
1,277 |
$24K |
| 85027 |
|
2,339 |
2,221 |
$22K |
| 59025 |
Fetal non-stress test |
103 |
67 |
$22K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
40 |
37 |
$21K |
| 86780 |
|
1,080 |
1,070 |
$21K |
| 87632 |
|
55 |
54 |
$20K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
413 |
216 |
$20K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
180 |
146 |
$19K |
| J3490 |
Unclassified drugs |
6,817 |
2,805 |
$18K |
| 73130 |
|
184 |
167 |
$17K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
55 |
55 |
$17K |
| 87186 |
|
1,286 |
1,212 |
$17K |
| 83880 |
|
500 |
465 |
$17K |
| 80061 |
Lipid panel |
1,086 |
1,042 |
$17K |
| 82077 |
|
928 |
793 |
$16K |
| 86803 |
|
770 |
763 |
$16K |
| 83735 |
|
1,830 |
1,654 |
$16K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
108 |
107 |
$16K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
146 |
142 |
$13K |
| 92557 |
|
88 |
88 |
$13K |
| 92567 |
|
229 |
226 |
$13K |
| 81003 |
|
2,853 |
2,718 |
$13K |
| 82962 |
|
1,543 |
1,010 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
287 |
284 |
$11K |
| 82805 |
|
155 |
144 |
$11K |
| 85379 |
|
631 |
611 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
279 |
277 |
$10K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
284 |
284 |
$10K |
| 85610 |
|
1,429 |
1,166 |
$9K |
| 76830 |
Ultrasound, transvaginal |
70 |
70 |
$9K |
| 87081 |
|
724 |
718 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
664 |
564 |
$9K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
12 |
$9K |
| 94762 |
|
102 |
86 |
$8K |
| 87481 |
|
188 |
182 |
$8K |
| 36000 |
|
840 |
792 |
$8K |
| Q3014 |
Telehealth originating site facility fee |
141 |
125 |
$7K |
| 86140 |
|
1,206 |
1,145 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
178 |
171 |
$7K |
| 86850 |
|
530 |
514 |
$7K |
| 87430 |
|
333 |
330 |
$7K |
| 84702 |
|
229 |
178 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,713 |
1,447 |
$6K |
| 87480 |
|
177 |
173 |
$5K |
| 87510 |
|
177 |
173 |
$5K |
| 87660 |
|
177 |
173 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
88 |
78 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
441 |
401 |
$5K |
| 81514 |
|
12 |
12 |
$5K |
| 86900 |
|
595 |
565 |
$5K |
| 90715 |
|
221 |
219 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,891 |
1,401 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
119 |
68 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$4K |
| 83550 |
|
333 |
321 |
$4K |
| 93976 |
|
16 |
16 |
$3K |
| 82570 |
|
499 |
471 |
$3K |
| 86901 |
|
591 |
562 |
$3K |
| 83540 |
|
372 |
359 |
$3K |
| 87340 |
|
193 |
192 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,329 |
1,219 |
$3K |
| 82043 |
|
396 |
382 |
$3K |
| 73110 |
|
26 |
25 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
152 |
148 |
$3K |
| 86787 |
|
125 |
119 |
$2K |
| 72100 |
|
14 |
14 |
$2K |
| 80074 |
|
28 |
28 |
$2K |
| 10060 |
|
17 |
15 |
$2K |
| 87653 |
|
36 |
36 |
$2K |
| 86762 |
|
93 |
91 |
$2K |
| 85652 |
|
412 |
390 |
$2K |
| 87070 |
|
136 |
130 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,423 |
1,288 |
$2K |
| 87075 |
|
64 |
61 |
$1K |
| 80143 |
|
67 |
64 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$1K |
| 96367 |
|
28 |
26 |
$1K |
| 83655 |
|
62 |
62 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
324 |
206 |
$1K |
| 80179 |
|
56 |
52 |
$1K |
| 97161 |
|
38 |
38 |
$1K |
| 97162 |
|
12 |
12 |
$1K |
| 87205 |
|
135 |
129 |
$893.15 |
| 99215 |
Prolong outpt/office vis |
45 |
42 |
$867.31 |
| 84703 |
|
62 |
61 |
$866.64 |
| 82550 |
|
108 |
107 |
$858.05 |
| 82010 |
|
74 |
60 |
$796.07 |
| 87807 |
|
38 |
35 |
$744.52 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
575 |
457 |
$727.80 |
| 82607 |
|
48 |
45 |
$696.35 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
121 |
110 |
$613.19 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
318 |
283 |
$595.89 |
| 82140 |
|
43 |
40 |
$587.82 |
| 81002 |
|
183 |
173 |
$553.27 |
| 83516 |
|
24 |
14 |
$544.55 |
| 90670 |
|
43 |
42 |
$510.41 |
| 11721 |
|
23 |
12 |
$502.30 |
| 82947 |
|
65 |
64 |
$398.21 |
| 86038 |
|
28 |
28 |
$386.31 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
74 |
74 |
$259.94 |
| 80050 |
General health panel |
14 |
14 |
$252.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
187 |
179 |
$238.63 |
| 82375 |
|
15 |
13 |
$228.29 |
| 94760 |
|
15 |
12 |
$227.17 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
58 |
46 |
$155.58 |
| 82784 |
|
15 |
15 |
$142.24 |
| J2060 |
Injection, lorazepam, 2 mg |
46 |
39 |
$122.39 |
| G0008 |
Administration of influenza virus vaccine |
29 |
29 |
$98.67 |
| 86431 |
|
14 |
14 |
$92.84 |
| 85018 |
|
14 |
14 |
$60.24 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$54.94 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
52 |
51 |
$48.98 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
85 |
78 |
$44.77 |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
13 |
13 |
$43.61 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
18 |
17 |
$25.09 |
| J1815 |
Injection, insulin, per 5 units |
38 |
17 |
$8.27 |
| 97799 |
|
25 |
16 |
$0.04 |